Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Dept Of Ophthalmology, |
RCV003889706 | SCV004704984 | uncertain significance | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Ambry Genetics | RCV004369722 | SCV004886181 | uncertain significance | Inborn genetic diseases | 2023-11-21 | criteria provided, single submitter | clinical testing | The c.2717G>T (p.R906L) alteration is located in exon 21 (coding exon 19) of the IFT140 gene. This alteration results from a G to T substitution at nucleotide position 2717, causing the arginine (R) at amino acid position 906 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005015081 | SCV005642772 | uncertain significance | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2024-04-28 | criteria provided, single submitter | clinical testing |